AAAAAA

   
Results: 1-8 |
Results: 8
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin
Authors: Zellweger, T Miyake, H July, LV Akbari, M Kiyama, S Gleave, ME
Citation: T. Zellweger et al., Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin, NEOPLASIA, 3(4), 2001, pp. 360-367
Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells
Authors: Miyake, H Hara, S Zellweger, T Kamidono, S Gleave, ME Hara, I
Citation: H. Miyake et al., Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells, MOL UROL, 5(3), 2001, pp. 105-111
Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer
Authors: Gleave, ME Miyake, H Zellweger, T Chi, K July, L Nelson, C Rennie, P
Citation: Me. Gleave et al., Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer, UROLOGY, 58(2A), 2001, pp. 39-48
Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2 '-O-(2-methoxy)ethyl chemistry
Authors: Zellweger, T Miyake, H Cooper, S Chi, K Conklin, BS Monia, BP Gleave, ME
Citation: T. Zellweger et al., Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2 '-O-(2-methoxy)ethyl chemistry, J PHARM EXP, 298(3), 2001, pp. 934-940
Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model
Authors: Leung, S Miyake, H Zellweger, T Tolcher, A Gleave, ME
Citation: S. Leung et al., Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model, INT J CANC, 91(6), 2001, pp. 846-850
Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer
Authors: Neuhaus, M Wagner, U Schmid, U Ackermann, D Zellweger, T Maurer, R Alund, G Knonagel, H Rist, M Moch, H Mihatsch, MJ Gasser, TC Sauter, G
Citation: M. Neuhaus et al., Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer, HUMAN PATH, 30(1), 1999, pp. 81-86
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer
Authors: Wagner, U Suess, K Luginbuhl, T Schmid, U Ackermann, D Zellweger, T Maurer, R Alund, G Knonagel, H Rist, M Jordan, P Moch, H Mihatsch, MJ Gasser, TC Sauter, G
Citation: U. Wagner et al., Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer, J PATHOLOGY, 188(1), 1999, pp. 44-50
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)
Authors: Zhao, JM Richter, J Wagner, U Roth, B Schraml, P Zellweger, T Ackermann, D Schmid, U Moch, H Mihatsch, MJ Gasser, TC Sauter, G
Citation: Jm. Zhao et al., Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa), CANCER RES, 59(18), 1999, pp. 4658-4661
Risultati: 1-8 |